Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP): effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma
Journal Article
·
· Cancer Treat. Rep.; (United States)
OSTI ID:6010191
Twenty-three patients with metastatic non-oat cell bronchogenic carcinoma (MN0BC) were treated with cyclophosphamide, adriamycin, methotrexate,and procarbazine (CAMP) after radiation therapy. Objective responses were seen in 11 of 23 patients (48%) with a projected median survival time of 12.5 months for responding patients and patients with stable disease. Lung, liver, and cutaneous sites of involvement proved to be highly responsive; bone involvement was less responsive. CAMP is an effective combination in the treatment of MNOBC and its use in patients with less advanced disease should be explored.
- OSTI ID:
- 6010191
- Journal Information:
- Cancer Treat. Rep.; (United States), Journal Name: Cancer Treat. Rep.; (United States) Vol. 60:9; ISSN CTRRD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study. [/sup 60/Co]
Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity
Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study
Journal Article
·
Tue Jun 01 00:00:00 EDT 1982
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6783081
Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity
Conference
·
Wed Aug 01 00:00:00 EDT 1979
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5339501
Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study
Journal Article
·
Wed Jan 31 23:00:00 EST 1990
· Cancer (Philadelphia); (USA)
·
OSTI ID:7190677
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560306* -- Chemicals Metabolism & Toxicology-- Man-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ALKYLATING AGENTS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMETABOLITES
ANTINEOPLASTIC DRUGS
BODY
CARBONIC ACID DERIVATIVES
CARCINOMAS
CHEMOTHERAPY
DIGESTIVE SYSTEM
DISEASES
DOXORUBICIN
DRUGS
ENDOXAN
EVALUATION
FRACTIONATED IRRADIATION
GLANDS
IMMUNOSUPPRESSIVE DRUGS
IRRADIATION
LIFE SPAN
LIVER
LUNGS
MEDICINE
METASTASES
METHOTREXATE
NAUSEA
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PATIENTS
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
SYMPTOMS
THERAPY
VOMITING
560306* -- Chemicals Metabolism & Toxicology-- Man-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ALKYLATING AGENTS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMETABOLITES
ANTINEOPLASTIC DRUGS
BODY
CARBONIC ACID DERIVATIVES
CARCINOMAS
CHEMOTHERAPY
DIGESTIVE SYSTEM
DISEASES
DOXORUBICIN
DRUGS
ENDOXAN
EVALUATION
FRACTIONATED IRRADIATION
GLANDS
IMMUNOSUPPRESSIVE DRUGS
IRRADIATION
LIFE SPAN
LIVER
LUNGS
MEDICINE
METASTASES
METHOTREXATE
NAUSEA
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PATIENTS
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
SYMPTOMS
THERAPY
VOMITING